DSIP Therapy: Complete Guide
Delta sleep-inducing peptide (DSIP) is a nonapeptide first described in 1977, isolated from the cerebral venous blood of rabbits during induced sleep. It has been studied for sleep regulation, stress response and pain, but the evidence base is small, old, and largely unreplicated. It has no approved medical use in any country.
Fact-checking at PeptideProbe is editorial, not clinical. Our editors check claims, dosing figures, and trial results against primary sources; they are not licensed clinicians and do not provide medical review. Nothing here is medical advice — talk to a qualified healthcare provider before starting any therapy.
What is DSIP?
Delta sleep-inducing peptide (DSIP) is a nonapeptide first described in 1977, isolated from the cerebral venous blood of rabbits during induced sleep. It has been studied for sleep regulation, stress response and pain, but the evidence base is small, old, and largely unreplicated. It has no approved medical use in any country.
How DSIP Works
DSIP works through specific biological pathways to produce its therapeutic effects. Consult with a qualified provider for detailed information about how this peptide therapy works for your specific condition.
Benefits & Uses
Investigated for sleep onset, stress modulation and chronic pain, mostly in small studies from the 1980s and 1990s. Modern replication is largely absent, so no benefit can be regarded as established.
Clinical Evidence & Research
Clinical research on DSIP continues to evolve. DSIP has been studied in preclinical and clinical settings. Speak with your provider about the current evidence base.
Side Effects & Safety
Poorly characterised. The published human exposure is limited and dated, so there is no reliable basis for describing common or rare adverse effects.
Dosing & Administration
Dosing protocols for DSIP should be determined by a qualified healthcare provider based on your individual health profile, treatment goals, and response to therapy. Self-dosing without medical supervision is not recommended.
Find DSIP Providers Near You
Search our directory for qualified providers offering DSIP therapy. Filter by location, telehealth, and more.
Browse ProvidersDSIP FAQ
Investigated for sleep onset, stress modulation and chronic pain, mostly in small studies from the 1980s and 1990s. Modern replication is largely absent, so no benefit can be regarded as established.
Costs vary by provider and location. Contact providers directly for current pricing.
DSIP has an FDA status of "Research". It is currently used in research and clinical settings. Consult with a qualified provider about its regulatory status and appropriate use.
Poorly characterised. The published human exposure is limited and dated, so there is no reliable basis for describing common or rare adverse effects.
PeptideProbe lists 0 providers offering DSIP therapy. Use our directory to search by location, filter by telehealth availability, and compare providers.
What DSIP is used for
Each of these reviews the evidence for that goal, including where it is weaker than the marketing suggests.
Stay Updated
Get notified when new peptide therapy providers join in your area.
Related Peptides
Medical Disclaimer: This content is for informational purposes only and should not be considered medical advice. Always consult with a qualified healthcare provider before beginning any peptide therapy treatment.